Granahan Investment Management, LLC Cerus Corp Transaction History

Granahan Investment Management, LLC

  • $2.38 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$4.81 - $6.99 $3.11 Million - $4.51 Million
-645,565 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$5.97 - $7.93 $6.85 Million - $9.1 Million
-1,147,690 Reduced 64.0%
645,565 $4.4 Million
Q3 2021

Nov 15, 2021
BUY
$4.79 - $6.68 $5.44 Million - $7.58 Million
1,135,308 Added 172.55%
1,793,255 $10.9 Million
Q2 2021

Aug 16, 2021
SELL
$5.35 - $6.35 $448,897 - $532,803
-83,906 Reduced 11.31%
657,947 $3.89 Million
Q1 2021

May 17, 2021
BUY
$5.68 - $7.87 $4.21 Million - $5.84 Million
741,853 New
741,853 $4.46 Million

Others Institutions Holding CERS

# of Institutions
156
Shares Held
147M
Call Options Held
84.2K
Put Options Held
55.5K
View Full List

About CERUS CORP

CERS Quotes by TradingView
  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $317M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Granahan Investment Management, LLC Portfolio

Follow Granahan Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granahan Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email